Article info

Download PDFPDF
Original research
Neutrophil activation in patients treated with endovascular therapy is associated with unfavorable outcomes and mitigated by intravenous thrombolysis

Authors

  • Benjamin Maïer Interventional Neuroradiology Department, Fondation Rothschild Hospital, Paris, France UMRS-1144, Optimisation Thérapeutique en Neuropsychopharmacologie, F-75006 Paris, France, Université de Paris Cité, Inserm, Paris, France Neurology Department, Hôpital Saint-Joseph, Paris, France FHU NeuroVasc, Paris, France PubMed articlesGoogle scholar articles
  • Lucas Di Meglio Interventional Neuroradiology Department, Fondation Rothschild Hospital, Paris, France UMRS-1144, Optimisation Thérapeutique en Neuropsychopharmacologie, F-75006 Paris, France, Université de Paris Cité, Inserm, Paris, France PubMed articlesGoogle scholar articles
  • Jean-Philippe Desilles Interventional Neuroradiology Department, Fondation Rothschild Hospital, Paris, France UMRS-1144, Optimisation Thérapeutique en Neuropsychopharmacologie, F-75006 Paris, France, Université de Paris Cité, Inserm, Paris, France FHU NeuroVasc, Paris, France PubMed articlesGoogle scholar articles
  • Mialitiana Solo Nomenjanahary UMRS-1144, Optimisation Thérapeutique en Neuropsychopharmacologie, F-75006 Paris, France, Université de Paris Cité, Inserm, Paris, France PubMed articlesGoogle scholar articles
  • François Delvoye Interventional Neuroradiology Department, Fondation Rothschild Hospital, Paris, France PubMed articlesGoogle scholar articles
  • Maeva Kyheng Interventional Neuroradiology Department, Fondation Rothschild Hospital, Paris, France PubMed articlesGoogle scholar articles
  • Perrine Boursin Interventional Neuroradiology Department, Fondation Rothschild Hospital, Paris, France PubMed articlesGoogle scholar articles
  • Véronique Ollivier UMRS-1144, Optimisation Thérapeutique en Neuropsychopharmacologie, F-75006 Paris, France, Université de Paris Cité, Inserm, Paris, France PubMed articlesGoogle scholar articles
  • Sébastien Dupont UMRS-1144, Optimisation Thérapeutique en Neuropsychopharmacologie, F-75006 Paris, France, Université de Paris Cité, Inserm, Paris, France PubMed articlesGoogle scholar articles
  • Thomas Rambaud UMRS-1144, Optimisation Thérapeutique en Neuropsychopharmacologie, F-75006 Paris, France, Université de Paris Cité, Inserm, Paris, France PubMed articlesGoogle scholar articles
  • Mylène Hamdani Interventional Neuroradiology Department, Fondation Rothschild Hospital, Paris, France PubMed articlesGoogle scholar articles
  • Julien Labreuche Department of Biostatistics, CHU Lille, 59000 Lille, France PubMed articlesGoogle scholar articles
  • Raphaël Blanc Interventional Neuroradiology Department, Fondation Rothschild Hospital, Paris, France PubMed articlesGoogle scholar articles
  • Michel Piotin Interventional Neuroradiology Department, Fondation Rothschild Hospital, Paris, France PubMed articlesGoogle scholar articles
  • Jean-Michel Halimi Nephrology Department, Tours Hospital, Tours, France EA4245-Transplantation, Immunology and Inflammation, University of Tours, Tours, France PubMed articlesGoogle scholar articles
  • Mikaël Mazighi Interventional Neuroradiology Department, Fondation Rothschild Hospital, Paris, France UMRS-1144, Optimisation Thérapeutique en Neuropsychopharmacologie, F-75006 Paris, France, Université de Paris Cité, Inserm, Paris, France FHU NeuroVasc, Paris, France Department of Neurology, Lariboisiere Hospital, Université Paris Cité, Paris, France PubMed articlesGoogle scholar articles
  • Benoit Ho-Tin-Noe UMRS-1144, Optimisation Thérapeutique en Neuropsychopharmacologie, F-75006 Paris, France, Université de Paris Cité, Inserm, Paris, France PubMed articlesGoogle scholar articles
  • on behalf of the NEUTROSTROKE investigators
    Google scholar articles
  1. Correspondence to Dr Benoit Ho-Tin-Noe, INSERM U1148, Paris, France; benoit.ho-tin-noe{at}inserm.fr
View Full Text

Citation

Maïer B, Di Meglio L, Desilles J on behalf of the NEUTROSTROKE investigators, et al
Neutrophil activation in patients treated with endovascular therapy is associated with unfavorable outcomes and mitigated by intravenous thrombolysis

Publication history

  • Received December 21, 2022
  • Accepted March 25, 2023
  • First published April 17, 2023.
Online issue publication 
January 12, 2024

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.